116 related articles for article (PubMed ID: 6679721)
1. Use of non-physiological buffer systems in the analysis of methotrexate transport in L1210 cells.
Henderson GB; Zevely EM
Biochem Int; 1983 Apr; 6(4):507-15. PubMed ID: 6679721
[TBL] [Abstract][Full Text] [Related]
2. The issues of transport multiplicity and energetics pertaining to methotrexate efflux in L1210 cells addressed by an analysis of cis and trans effects of inhibitors.
Sirotnak FM; O'Leary DF
Cancer Res; 1991 Mar; 51(5):1412-7. PubMed ID: 1997179
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of folate analogue transport inward in L1210 cells during methotrexate therapy of leukemic mice: evidence of the nature of the effect, possible host mediation, and pharmacokinetic significance.
Sirotnak FM; Poser RE; Barrueco JR
Cancer Res; 1987 Oct; 47(20):5334-9. PubMed ID: 3498533
[TBL] [Abstract][Full Text] [Related]
4. Relative frequency and kinetic properties of transport-defective phenotypes among methotrexate-resistant L1210 clonal cell lines derived in vivo.
Sirotnak FM; Moccio DM; Kelleher LE; Goutas LJ
Cancer Res; 1981 Nov; 41(11 Pt 1):4447-52. PubMed ID: 7306968
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the transport mechanism for methotrexate in L1210 mouse leukemia cells.
Henderson GB
Prog Clin Biol Res; 1983; 132B():415-23. PubMed ID: 6634763
[TBL] [Abstract][Full Text] [Related]
6. Identification of the bromosulfophthalein-sensitive efflux route for methotrexate as the site of action of vincristine in the vincristine-dependent enhancement of methotrexate uptake in L1210 cells.
Henderson GB; Tsuji JM
Cancer Res; 1988 Nov; 48(21):5995-6001. PubMed ID: 2844396
[TBL] [Abstract][Full Text] [Related]
7. Extent of the requirement for folate transport by L1210 cells for growth and leukemogenesis in vivo.
Sirotnak FM; Goutas LJ; Mines LS
Cancer Res; 1985 Oct; 45(10):4732-4. PubMed ID: 3875399
[TBL] [Abstract][Full Text] [Related]
8. Increased accumulation of methotrexate by murine tumor cells in vitro in the presence of probenecid which is mediated by a preferential inhibition of efflux.
Sirotnak FM; Moccio DM; Young CW
Cancer Res; 1981 Mar; 41(3):966-70. PubMed ID: 7459883
[TBL] [Abstract][Full Text] [Related]
9. Energy-dependent efflux of methotrexate in L1210 leukemia cells. Evidence for the role of an ATPase obtained with inside-out plasma membrane vesicles.
Schlemmer SR; Sirotnak FM
J Biol Chem; 1992 Jul; 267(21):14746-52. PubMed ID: 1386081
[TBL] [Abstract][Full Text] [Related]
10. Initial rate kinetics and evidence for duality of mediated transport of adenosine, related purine nucleosides, and nucleoside analogues in L1210 cells.
Chello PL; Sirotnak FM; Dorick DM; Yang CH; Montgomery JA
Cancer Res; 1983 Jan; 43(1):97-103. PubMed ID: 6847787
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the individual transport routes that mediate the influx and efflux of methotrexate in CCRF-CEM human lymphoblastic cells.
Henderson GB; Tsuji JM; Kumar HP
Cancer Res; 1986 Apr; 46(4 Pt 1):1633-8. PubMed ID: 3948152
[TBL] [Abstract][Full Text] [Related]
12. Methotrexate efflux in L1210 cells. Kinetic and specificity properties of the efflux system sensitive to bromosulfophthalein and its possible identity with a system which mediates the efflux of 3',5'-cyclic AMP.
Henderson GB; Tsuji JM
J Biol Chem; 1987 Oct; 262(28):13571-8. PubMed ID: 2820975
[TBL] [Abstract][Full Text] [Related]
13. Cyclic adenosine 3':5'-monophosphate and methotrexate transport in L1210 cells.
Henderson GB; Zevely EM; Huennekens FM
Cancer Res; 1978 Mar; 38(3):859-61. PubMed ID: 203390
[TBL] [Abstract][Full Text] [Related]
14. Interaction of chemotherapeutic agents with methotrexate and 5-fluorouracil and its effect on de novo DNA synthesis.
Bruckner HW; Schreiber C; Waxman S
Cancer Res; 1975 Mar; 35(3):801-6. PubMed ID: 1116135
[TBL] [Abstract][Full Text] [Related]
15. The mechanism of transport of the multitargeted antifolate (MTA) and its cross-resistance pattern in cells with markedly impaired transport of methotrexate.
Zhao R; Babani S; Gao F; Liu L; Goldman ID
Clin Cancer Res; 2000 Sep; 6(9):3687-95. PubMed ID: 10999762
[TBL] [Abstract][Full Text] [Related]
16. ATP-dependent efflux of 2,4-dinitrophenyl-S-glutathione. Properties of two distinct transport systems in inside-out vesicles from L1210 cells and a variant subline with altered efflux of methotrexate and cholate.
Saxena M; Henderson GB
J Biol Chem; 1995 Mar; 270(10):5312-9. PubMed ID: 7890643
[TBL] [Abstract][Full Text] [Related]
17. Effect of modification of plasma membrane fatty acid composition on fluidity and methotrexate transport in L1210 murine leukemia cells.
Burns CP; Luttenegger DG; Dudley DT; Buettner GR; Spector AA
Cancer Res; 1979 May; 39(5):1726-32. PubMed ID: 218733
[No Abstract] [Full Text] [Related]
18. Characterization of the multiple transport routes for methotrexate in L1210 cells using phthalate as a model anion substrate.
Henderson GB; Zevely EM
J Membr Biol; 1985; 85(3):263-8. PubMed ID: 3897547
[TBL] [Abstract][Full Text] [Related]
19. Alterations in the kinetics of methotrexate transport during growth of L1210 murine leukemia cells in culture.
Chello PL; Sirotnak FM; Dorick DM
Mol Pharmacol; 1980 Sep; 18(2):274-80. PubMed ID: 7421795
[No Abstract] [Full Text] [Related]
20. Activity of free and carrier-bound methotrexate against transport-deficient and high dihydrofolate dehydrogenase-containing methotrexate-resistant L1210 cells.
Chu BC; Fan CC; Howell SB
J Natl Cancer Inst; 1981 Jan; 66(1):121-4. PubMed ID: 6935452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
